MedPath

An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000008369
Lead Sponsor
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with allergies to insulin aspart or detemir 2)None type 2 diabetes 3)Medical history and/or complication of diabetic ketoacidosis 4)Medical history and/or complication of severe hypoglycemia 5)Treatment with insulin, DPP-4 inhibitor or GLP-1 analogue within 4 weeks prior to the study 6)Treatment with glucocorticoid 7)Uncontrolled hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 8)Patients with proliferative retinopathy or maculopathy 9)Medical history and/or malignancy 10)Severe complications and problems not suitable for the study 11)Pregnant or lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
M values
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath